Search

Your search keyword '"Sheridan, David"' showing total 419 results

Search Constraints

Start Over You searched for: Author "Sheridan, David" Remove constraint Author: "Sheridan, David" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
419 results on '"Sheridan, David"'

Search Results

2. National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022

3. Addressing the Pediatric Mental Health Crisis in Emergency Departments in the US: Findings of a National Pediatric Boarding Consensus Panel

10. The Role of Nonclassroom Spaces in Living-Learning Communities

11. Urinary Catheterization in Infants: When It’s Knot so Simple

13. Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study

14. National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022

15. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis

16. Willingness to Vaccinate Children against Influenza after the Coronavirus Disease 2019 Pandemic

17. Impact of social media "challenges" on poison center case volume for intentional ingestions among school-aged children: an observational study.

18. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

19. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

24. (Re)Mediating (Un)Heard Resonances: Tracing the Rhythms of Aurality in a Residential College Community

27. Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.

30. Addressing the Pediatric Mental Health Crisis in Emergency Departments in US: Findings of a National Pediatric Boarding Consensus Panel

31. Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review

35. Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

43. A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

Catalog

Books, media, physical & digital resources